EPS (Diluted) for Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current diluted EPS (TTM) is $-6.41. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
INSM
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$-6.41
YoY change
+15.1%
5Y CAGR
N/A
Peak year (2009)
$9.30
Latest annual
$-6.41
EPS (Diluted) history chart for Insmed (INSM) from 1999 to 2025
EPS (Diluted) history table for Insmed (INSM) from 1999 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $-6.41 | +15.1% | ||
| 2024 | $-5.57 | +4.3% | ||
| 2023 | $-5.34 | +36.6% | ||
| 2022 | $-3.91 | +0.8% | ||
| 2021 | $-3.88 | +28.9% | ||
| 2020 | $-3.01 | 0.0% | ||
| 2019 | $-3.01 | -28.7% | ||
| 2018 | $-4.22 | +46.0% | ||
| 2017 | $-2.89 | +1.4% | ||
| 2016 | $-2.85 | +41.1% | ||
| 2015 | $-2.02 | +9.8% | ||
| 2014 | $-1.84 | +15.0% | ||
| 2013 | $-1.60 | +2.6% | ||
| 2012 | $-1.56 | -39.1% | ||
| 2011 | $-2.56 | +422.4% | ||
| 2010 | $-0.49 | -105.3% | ||
| 2009 | $9.30 | -826.6% | ||
| 2008 | $-1.28 | -26.4% | ||
| 2007 | $-1.74 | -70.5% | ||
| 2006 | $-5.89 | -29.9% | ||
| 2005 | $-8.40 | +20.9% | ||
| 2004 | $-6.95 | +140.5% | ||
| 2003 | $-2.89 | -73.8% | ||
| 2002 | $-11.01 | -2.7% | ||
| 2001 | $-11.31 | -74.1% | ||
| 2000 | $-43.60 | +76.5% | ||
| 1999 | $-24.70 | — |
EPS (Diluted) values are taken from Insmed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for Insmed (INSM) came in at $-6.41 – grew 15.1% year-over-year.
Between 2009 and 2025, Insmed diluted EPS plunged 168.9%, falling from $9.30 to $-6.41.
2009 marks the peak diluted EPS at $9.30, with the historical low of $-43.60 recorded in 2000.
Among 8 Healthcare peers, Insmed (INSM) ranks 9th; the peer median for diluted EPS is $13.16.
Insmed EPS (Diluted) by Year
Insmed EPS (Diluted) 2025: $-6.41
Insmed diluted EPS in 2025 was $-6.41, grew 15.1% from 2024.
Insmed EPS (Diluted) 2024: $-5.57
Insmed diluted EPS in 2024 was $-5.57, edged up 4.3% from 2023.
Insmed EPS (Diluted) 2023: $-5.34
Insmed diluted EPS in 2023 was $-5.34, surged 36.6% from 2022.
Insmed EPS (Diluted) 2022: $-3.91
Insmed diluted EPS in 2022 was $-3.91, edged up 0.8% from 2021.
Insmed EPS (Diluted) 2021: $-3.88
Insmed diluted EPS in 2021 was $-3.88.
See more financial history for Insmed (INSM).
Sector peers — EPS (Diluted)
Companies in the same sector as Insmed, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Insmed's diluted EPS?
- Latest reported diluted EPS for Insmed (INSM) is $-6.41 (period ending December 31, 2025).
How has Insmed diluted EPS changed year-over-year?
- Insmed (INSM) diluted EPS changed +15.1% year-over-year on the latest annual filing.
When did Insmed diluted EPS hit its highest annual value?
- Insmed diluted EPS reached its highest annual value of $9.30 in 2009.
What was Insmed diluted EPS in 2024?
- Insmed (INSM) diluted EPS in 2024 was $-5.57.
What was Insmed diluted EPS in 2025?
- Insmed (INSM) diluted EPS in 2025 was $-6.41.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INSM Overview
Company profile, financial tools, and key metrics
INSM Revenue Counter
Earns $19.23 every second. See per minute, hour, and day.
INSM Earnings Counter
Loses −$40.49 per second. See per minute, hour, and day.
INSM Economic Scale
Exceeds Micronesia, Fed. Sts.'s GDP. Compare with world economies.
INSM What If Invested
What if you had invested $1,000? See historical returns from any date.
INSM How It Makes Money
Discover visual breakdown of $606.42M in revenue — where it comes from and where it goes.
INSM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INSM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INSM Daily Price Character
Explosive · 46.7% historical win rate (green days). Streaks & record days.
INSM Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.
INSM Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.